Penningtons Manches Cooper advises Jumo Health on merger with Falfurrias Capital Partners

Posted: 19/08/2024

The corporate team at Penningtons Manches Cooper has advised on the UK aspects of the merger of Jumo Health and Falfurrias Capital Partners. The team acted for Jumo Health, Inc (Delaware corporation), and its wholly owned subsidiary, UK company Jumo Health Limited, on this deal under Delaware law.

The team worked closely with Jumo’s US counsel, Wyrick, providing input on the UK aspects of the main US transactional documents, and assisted with the legal due diligence process, as well as UK tax advice on specific issues that arose. Canaccord Genuity LLC acted as the corporate finance advisor.

Headquartered in New Haven, Connecticut, Jumo Health creates educational resources tailored to different ages, cultures, and relatable experiences for patients and caregivers. With expertise in serving diverse populations, it covers over 160 health topics in more than 75 countries and 90 languages.

The Penningtons Manches Cooper team was led by global head of corporate, Matthew Martin, and associate Emily MacDonald. The wider team included corporate tax partner Oliver Gutman, consultant Stephen Goldstraw, and senior associate Leonie Langley, as well as company secretarial manager Richard Scampton and paralegal Ruba Sule-Braimah.

Kevin Aniskovich, president and CEO of Jumo Health, said: “Working with Matthew, Emily and the entire Penningtons Manches Cooper team was a pleasure. Engaging with field experts who were committed to ensuring Jumo Health’s priorities were effectively integrated into the deal significantly contributed to our successful outcome.”

Matthew Martin said: “We are delighted to have advised Jumo Health on this strategic merger with Falfurrias Capital Partners. This transaction further demonstrates Penningtons Manches Cooper’s strength in UK-US cross border M&A.”

Return to news headlines